Home › Cancro della cervice uterina › New York › New York City
Studi clinici su Cancro della cervice uterina a New York City, NY
19 studi su Cancro della cervice uterina cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- e altri 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 2
- Memorial Sloan Kettering Hospital, New York
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
In reclutamentoFase 4
- Columbia University Medical Center - Herbert Irving Pavilion, New York
- IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
In reclutamentoFase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6009), New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
In reclutamentoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
In reclutamentoFase 1/2
- Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
- Columbia University, New York
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
In reclutamentoFase 2
- Research Site, New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
In reclutamentoFase 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
In reclutamentoFase 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
In reclutamentoFase 1
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
In reclutamentoFase 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
In reclutamento
- Laura and Issac Perlmutter Cancer Center at NYU Langone-East 34th Street, New York
- Laura and Issac Perlmutter Cancer Center at NYU Langone, New York
- NYU Langone Medical Center (Tisch Hospital), New York
- e altri 3
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site 107, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, New York
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
In reclutamento
- Lenox Hill Hospital, New York
NYSCF Scientific Discovery Biobank
In reclutamentoStudio osservazionale
- New York Stem Cell Foundation Research Institute, New York
Studi su Cancro della cervice uterina in altre città
- Houston, TX34 studi
- Nashville, TN19 studi
- Boston, MA18 studi
- Arlington, VA16 studi
- Los Angeles, CA16 studi
- San Antonio, TX14 studi
- Dallas, TX13 studi
- St. Louis, MO13 studi
- Orlando, FL12 studi
- Chicago, IL12 studi
- Atlanta, GA11 studi
- Columbus, OH11 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.